Omeprazole or Ranitidine Plus Metoclopramide for Patients with Severe Erosive Oesophagitis
- 1 October 1995
- journal article
- clinical trial
- Published by Springer Nature in PharmacoEconomics
- Vol. 8 (4) , 343-349
- https://doi.org/10.2165/00019053-199508040-00008
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trialsJAMA, 1995
- Omeprazole is superior to ranitidine plus metoclopramide in the short‐term treatment of erosive oesophagitisAlimentary Pharmacology & Therapeutics, 1993
- Two doses of omeprazole versus placebo in symptomatic erosive esophagitis: The U.S. multicenter studyGastroenterology, 1992
- Healing and relapse of severe peptic esophagitis after treatment with omeprazoleGastroenterology, 1988
- Omeprazole (40 mg) is superior to ranitidine in short-term treatment of ulcerative reflux esophagitisDigestive Diseases and Sciences, 1988
- Omeprazole and ranitidine in treatment of reflux oesophagitis: double blind comparative trialBMJ, 1988
- Omeprazole or Ranitidine in the Treatment of Reflux Esophagitis: Results of a Double-Blind, Randomized, Scandinavian Multicenter StudyScandinavian Journal of Gastroenterology, 1987
- OMEPRAZOLE VERSUS RANITIDINE IN EROSIVE OESOPHAGITISThe Lancet, 1987
- DOUBLE-BLIND MULTICENTRE COMPARISON OF OMEPRAZOLE AND RANITIDINE IN THE TREATMENT OF REFLUX OESOPHAGITISThe Lancet, 1987
- Comparison of omeprazole and ranitidine in the treatment of reflux esophagitis.1986